Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2978 (LINC02978) is a member of the lincRNA (long intergenic non-coding RNA) family—transcripts longer than 200 nucleotides that are found between protein-coding genes and do not encode proteins[1][9]. It is annotated in human genome and functional gene catalogs, such as GeneCards and the GWAS Catalog, primarily as a non-coding RNA gene with an intergenic location[1][7]. While some lincRNAs have been implicated in gene expression regulation, chromatin modification, and other aspects of cellular regulation, the specific biological function, disease association, and therapeutic relevance of LINC02978 remain undetermined based on current public scientific data. No interacting proteins, drugs, or biomarker roles have been described for LINC02978; its relevance, if any, would most likely be as a putative regulator, but this remains speculative[1][3][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2978 (LINC02978).